The future of measuring and controlling postprandial glucose using TIR (Time in Range).Read More »
Technology and unique rapid-acting insulin can improve time in range and Quality of Life for patients with diabetes.Read More »
Newer glucagon products provide additional options for the treatment of severe hypoglycemia.
We were asked to consult on a case involving a 68-year-old man with type 1 diabetes (T1D). He recently experienced a severe hypoglycemic event resulting in hospitalization. The patient currently lives independently with his wife of 40 years and has had T1D since the age of 12....
Insulin delivery method or blood glucose monitoring – which is more important?Read More »
The study aimed to investigate whether testing HbA1c will improve cardiovascular disease risk assessment.Read More »
Can improving diabetes care be as simple as ensuring patients receive regular testing?Read More »
If dapagliflozin is the second medication prescribed to the patient after the first-line treatments of metformin or sulfonylurea, it has a greater impact.Read More »
A recent population-based cohort study offers more insight into the link between glycemic status and the risk for PD.Read More »
New diabetes mitigation plan in the intensive care unit during the COVID-19 pandemic.Read More »
Rushed communication between provider and patient is associated with reduced glycemic control in black patients.Read More »